Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells

Vascular Pharmacology
Beshay N M Zordoky, Ayman O S El-Kadi

Abstract

Doxorubicin is a potent anti-neoplastic antibiotic used to treat a wide variety of malignancies; however, its use is limited by dose dependent cardiotoxicity. There is indirect evidence suggesting that doxorubicin cardiotoxicity is CYP-mediated. In the current study, we investigated the effect of doxorubicin on hypertrophic markers, and different CYP gene expression in cardiac derived H9c2 cells. H9c2 cells were incubated with increasing concentrations of doxorubicin and the expressions of different genes were determined by real-time PCR. Our results demonstrate that multiple CYP genes are expressed in H9c2 cells and the level of expression from the highest to the lowest were; CYP1B1, CYP2B1, CYP2J3, CYP1A1, CYP2C11, CYP2C23, CYP2E1, CYP1A2, and CYP2B2. Doxorubicin treatment caused an induction of the hypertrophic markers, ANP and BNP. In addition, doxorubicin caused a significant induction of CYP1A1, CYP1A2, CYP1B1, CYP2B2, CYP2E1, and CYP2J3 gene expression in a concentration-dependent manner. However, only the highest concentration tested, 10 muM, caused an induction of CYP2C11; whereas, CYP2B1 and CYP2C23 were not altered. Our findings demonstrate that doxorubicin induces the hypertrophic markers, ANP and BNP as well as sev...Continue Reading

References

Mar 15, 1976·Experimental Cell Research·B W Kimes, B L Brandt
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·F BressolleJ F Rossi
Jun 15, 1985·Cancer·A U BuzdarG R Blumenschein
Mar 30, 1981·Toxicology and Applied Pharmacology·D J Marchand, K W Renton
Oct 30, 1999·Canadian Journal of Physiology and Pharmacology·J Di ReD S Riddick
Jan 6, 2000·Archives of Biochemistry and Biophysics·Q M ChenJ J Bahl
Feb 1, 2000·Biochemical and Biophysical Research Communications·T PelzerL Neyses
Apr 18, 2000·Lancet·T Thum, J Borlak
Jan 25, 2002·IUBMB Life·A MordenteG Minotti
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Victoria C TuQin M Chen
Jun 5, 2002·Current Opinion in Lipidology·Deanna L Kroetz, Darryl C Zeldin
Oct 9, 2002·Current Drug Metabolism·Thomas H Rushmore, A-N Tony Kong
Oct 11, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Thomas Thum, Jürgen Borlak
May 7, 2003·Trends in Cardiovascular Medicine·Yeshao WenJerry Nadler
May 21, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Sui WangMi-Sook Kim
Oct 13, 2004·Toxicology and Applied Pharmacology·Paulo J OliveiraKendall B Wallace
Dec 21, 2004·Toxicologic Pathology·Luksana ChaiswingTerry D Oberley
Mar 15, 2005·Cell Biology International·L SidorikN A Chaschin
Apr 19, 2005·Archives of Pharmacal Research·Changjiang XuAh-Ng Tony Kong
Jul 29, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David S RiddickDavid J Waxman
Aug 2, 2005·Biochemical and Biophysical Research Communications·Paolo SpallarossaAntonio Barsotti
Mar 22, 2006·Anti-cancer Drugs·Josefine PalleUNKNOWN Nordic Society for Pediatric Hematology and Oncology
Jul 11, 2006·Pharmacology & Therapeutics·Reem H Elbekai, Ayman O S El-Kadi
Jul 26, 2006·International Journal of Cardiology·Delia OutomuroJosé Milei
Jan 16, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tracy C DelozierJoyce A Goldstein
Jul 27, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Emilio ChiosiGennaro Illiano
Jul 31, 2007·Journal of Pharmacological and Toxicological Methods·Beshay N M Zordoky, Ayman O S El-Kadi
Sep 18, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Samir TurakhiaGovindasamy Ilangovan
Feb 12, 2008·American Journal of Physiology. Heart and Circulatory Physiology·C D VenkatakrishnanGovindasamy Ilangovan
Feb 22, 2008·Current Drug Metabolism·Beshay N M Zordoky, Ayman O S El-Kadi
May 9, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cheng FangXinxin Ding

❮ Previous
Next ❯

Citations

Sep 26, 2013·Journal of Integrative Medicine·Yong XiaoYue Gao
May 12, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Yunfang ZhangJohn M Seubert
May 18, 2011·Cellular and Molecular Life Sciences : CMLS·Katherine VerverisTom C Karagiannis
Jan 23, 2010·Pharmacology & Therapeutics·Beshay N M Zordoky, Ayman O S El-Kadi
Dec 9, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Beshay N M Zordoky, Ayman O S El-Kadi
Dec 14, 2017·Veterinary and Comparative Oncology·A CarlsonB N M Zordoky
May 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·Juan LiBaojian Wu
Apr 27, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Meetal SolankiKarl Herbert
Aug 8, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Abdulaziz M S AlsaadAyman O S El-Kadi
May 17, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Beshay N M ZordokyAyman O S El-Kadi
Jan 14, 2020·Antioxidants & Redox Signaling·Carmine RoccaTommaso Angelone
Feb 23, 2020·International Journal of Molecular Sciences·Marianne K O GrantBeshay N Zordoky
Apr 14, 2017·Oncotarget·Alini Trujillo-PaolilloSilvia Regina Caminada de Toledo
Jan 8, 2020·Naunyn-Schmiedeberg's Archives of Pharmacology·Zuoyan WangJianjun Peng
Jan 13, 2017·Biology of Sex Differences·Marianne K O GrantBeshay N Zordoky
Mar 4, 2021·Arquivos brasileiros de cardiologia·Zuoyan WangJianjun Peng
Nov 14, 2020·Clinical Science·Alexa N CarreraBeshay N Zordoky
Oct 3, 2009·Toxicology and Applied Pharmacology·Beshay N M ZordokyAyman O S El-Kadi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.